Position in ABT
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$5,753,732
+$5,753,732 QoQ
Shares Held
63,409
Ownership
0.004%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#648
of 2,959 holders
Holding Since
Mar 2025
2 quarters on record
Derivatives in ABT
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$936,769
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Fulcrum Asset Management LLP holds $10,730,982 across 21 Medical Devices names. ABT ranks #1 (53.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
63,409 | $5,753,732 | |
| 2 | BSX |
Boston Scientific Corp
|
47,763 | $2,038,524 | |
| 3 | PODD |
Insulet Corp
|
10,943 | $1,666,071 | |
| 4 | EW |
Edwards Lifesciences Corp
|
7,551 | $683,063 | |
| 5 | BIO |
Bio-Rad Laboratories, Inc.
|
924 | $271,295 | |
| 6 | QDEL |
QuidelOrtho Corp
|
6,708 | $117,524 | |
| 7 | CNMD |
CONMED Corp
|
1,840 | $60,223 | |
| 8 | AHCO |
AdaptHealth Corp.
|
3,904 | $40,679 |
All Filings in ABT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,753,732 | 63,409 | Shares | Sole | 2026-08-18 | |
| 2025-03-31 | $936,769 | 0 | Put | Sole | 2025-04-24 | |
| No filing history on record for this holder in this stock. | ||||||